HRT FINANCIAL LP

Position in KURA — Kura Oncology, Inc.

CIK 1475597 NEW YORK, NY

Position in KURA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,355,774

-$1,294,791 QoQ

Shares Held

214,747

-52.2% QoQ

Ownership

0.241%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#51

of 220 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. KURA ranks #51 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,355,774	214,747	-52.2%	Shares	Defined	2026-08-14
2026-03-31	$3,650,565	449,024	+358.1%	Shares	Defined	2026-05-14
2025-12-31	$1,018,521	98,029	-73.4%	Shares	Defined	2026-02-12
2025-09-30	$3,261,729	368,557	+75.5%	Shares	Defined	2025-11-14
2025-06-30	$1,211,573	209,978	+31.0%	Shares	Defined	2025-08-14
2025-03-31	$1,058,092	160,317	+264.3%	Shares	Defined	2025-05-15
2024-09-30	$859,896	44,007	+0.7%	Shares	Defined	2024-11-12
2024-06-30	$899,824	43,702	-53.6%	Shares	Defined	2024-08-12
2023-12-31	$1,355,732	94,279	+194.0%	Shares	Defined	2024-02-09
2022-03-31	$515,717	32,072	+99.9%	Shares	Defined	2022-05-16
2021-12-31	$224,644	16,046	-62.2%	Shares	Defined	2022-02-14
2021-09-30	$795,406	42,467	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.